http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2673729-C1
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_79ae6dd5bafbd2dd69035367385d754c |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-00 |
| filingDate | 2018-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c029e1d469c88b166be836dbceb4159d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b0d5e20d447a75bb2fc5cecb4ee5b646 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a6f965f9704fc52dd14c3005ab05718 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5a4be2da7be2ce11b9cc4ac2a442d01c |
| publicationDate | 2018-11-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2673729-C1 |
| titleOfInvention | Application of cell line of rc291c clear cell adenocarcinoma |
| abstract | FIELD: biotechnology.SUBSTANCE: invention is the use of the human cell carcinoma of the kidney cancer RC291C, expressing cancer-testicular antigens stored in the specialized collection of vertebrate cell cultures of the Russian cell culture collection under the registration number RKKK (P) 724D for the preparation of biomedical cell products and testing of antitumor bio-and chemotherapy drugs.EFFECT: invention allows to increase the effectiveness of treatment and increase the life expectancy in the treatment of malignant tumors.1 cl, 1 ex |
| priorityDate | 2018-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 164.